Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antigens, CD274
  • Pneumonia
  • Programmed Cell Death 1 Receptor

abstract

  • To our knowledge, this is the largest reported series of LR-NSCLC treated with definitive RT. Survival appears comparable to or greater than that of primary NSCLC. Subsequent LRF is more common than distant failure. Established prognostic factors for primary NSCLC, such as chemotherapy and stage, were not clearly prognostic in this analysis. IMRT and higher RT doses were associated with improved survival, though IMRT patients were also treated more recently. These data support definitive-intent RT with optimal dose and technique in such patients.

publication date

  • November 26, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5413410

Digital Object Identifier (DOI)

  • 10.1016/j.cllc.2017.01.014

PubMed ID

  • 28302437

Additional Document Info